PubMed

The road to market implantable drug delivery systems: a review on US FDA's regulatory framework and quality control requirements.

PMID: 30084277 · 2018-10-10

S, a, n, a, , A, l, -, J, a, w, a, d, i, ;, , P, i, e, r, , C, a, p, a, s, s, o, ;, , M, a, n, i, s, h, a, , S, h, a, r, m, a

RevistaPharmaceutical development and technology

Año2018-10-10

PMID30084277

Resumen

The scope of Implantable Drug Delivery Systems (IDDSs) comprehends a variety of sterile therapeutic implements placed inside the body to exert a certain therapeutic action for extended duration. They are classified under different categories from pharmaceutical science and regulatory perspectives. The novelty and variety of IDDSs prevent the application of a uniform regulation for all IDDS products; therefore, sponsors face regulatory challenges to register and market their products. This review

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.